InspireMD (NSPR) Shares Up 14.3%

InspireMD Inc (NYSEAMERICAN:NSPR)’s share price shot up 14.3% on Tuesday . The company traded as high as $0.17 and last traded at $0.16. 21,913,100 shares traded hands during trading, an increase of 4,244% from the average session volume of 504,408 shares. The stock had previously closed at $0.14.

TRADEMARK VIOLATION WARNING: “InspireMD (NSPR) Shares Up 14.3%” was first reported by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/3079334/inspiremd-nspr-shares-up-14-3.html.

About InspireMD

InspireMD, Inc is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures.

Receive News & Ratings for InspireMD Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.